If we assume that the reported bone and liver cancers in the data set are indeed first primaries, the data suggest no association with BRCA1 PVs, but that BRCA2 carriers are at seven-fold increased risk of bone cancer and five-fold increased risk of liver cancer without significant differences between males and females (Data Supplement). This evidence concerns the gene BRCA1 and liver cancer.